Perbedaan Indofarma Tbk. dan Jayamas Medica Industri Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Jayamas Medica Industri Tbk. diperdagangkan di Rp214 (kapitalisasi pasar 5,79 T, volume 24 jam 9,53 jt). Perbedaan utamanya: Jayamas Medica Industri Tbk. jauh lebih besar — sekitar 14,8× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | OMED | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 5,79 T |
Volume | — | 9,53 jt |
Lot | — | 95,3 rb |
Perputaran | — | 2,05 M |
Harga Rata-rata | — | 215,03 |
Nilai Transaksi | — | 2,05 M |
Harga Ekuilibrium Indikatif | — | 214 |
Volume Ekuilibrium Indikatif | — | 1,69 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Selengkapnya di halaman OMED →